SCOPOLAMINE Side Effects

7021189-4 | Laceration, Vitreous Detachment
on Sep 22, 2010 Male patient from FRANCE , 65 years of age, was diagnosed with motion sickness (What is motion sickness?) and was treated with Scopolamine (View Usage). Patient experienced the following unwanted or unexpected effects: laceration, vitreous detachment. Scopolamine dosage: Unk, Unk.

7010907-7 | Chills, Dizziness, Dry Mouth, Headache, Impaired Work Ability, Nausea, Somnolence, Vision Blurred
Patient was taking Scopolamine (View Usage). Patient had the following side effects: chills, dizziness (What is dizziness?), dry mouth, headache (What is headache?), impaired work ability, nausea (What is nausea?), somnolence, vision blurred on Sep 23, 2010 from UNITED STATES Additional patient health information: Female patient , 61 years of age, weighting 165.0 lb, was diagnosed with motion sickness (What is motion sickness?) and. Scopolamine dosage: Transderm.

6991631-3 | Dizziness, Mental Disorder, Nausea
Adverse event was reported on Sep 09, 2010 by a Male patient taking Scopolamine (View Usage) (Dosage: 1 Df, Q72h) was diagnosed with motion sickness (What is motion sickness?) and. Location: GERMANY , weighting 158.7 lb, After Scopolamine was administered, patient had the following side effects: dizziness (What is dizziness?), mental disorder, nausea (What is nausea?).

6937371-8 | Retinal Detachment
on Aug 17, 2010 Male patient from FRANCE , 65 years of age, was diagnosed with motion sickness (What is motion sickness?) and was treated with Scopolamine (View Usage). Patient experienced the following unwanted or unexpected effects: retinal detachment. Scopolamine dosage: Unk, Unk.


6862981-6 | Blister, Off Label Use, Pain Of Skin, Skin Irritation
on Jul 15, 2010 Male patient from UNITED KINGDOM , 80 years of age, was diagnosed with salivary hypersecretion and was treated with Scopolamine (View Usage). Patient had the following side effects: blister, off label use, pain of skin, skin irritation. Scopolamine dosage: 1 Mg, Q72h.

6820366-2 | Concomitant Disease Progression, Hyperhidrosis, Malignant Neoplasm Progression, Off Label Use, Product Adhesion Issue
Patient was taking Scopolamine (View Usage). After Scopolamine was administered, patient had the following side effects: concomitant disease progression, hyperhidrosis, malignant neoplasm progression, off label use, product adhesion issue on Jul 05, 2010 from GERMANY Additional patient health information: Male patient , weighting 143.3 lb, was diagnosed with palliative care (What is palliative care?) and. Scopolamine dosage: Unk,unk. During the same period patient was treated with MORPHINE (Unk,unk) (View Morphine Review and Morphine Label ), FENTANYL (Unk,unk) (View Fentanyl Review and Fentanyl Label ), TRAMADOL (Unk,unk) (View Tramadol Review and Tramadol Label ), FLUCONAZOLE (Unk,unk) (View Fluconazole Review and Fluconazole Label ), METOPROLOL (Unk,unk) (View Metoprolol Review and Metoprolol Label ), METAMIZOLE (Unk,unk) (View Metamizole Review and Metamizole Label ), AMOXICILINA + CLAVULANICO (Unk,unk) (View Amoxicilina + Clavulanico Review and Amoxicilina + Clavulanico Label ), LORAZEPAM (Unk,unk) (View Lorazepam Review and Lorazepam Label ).

6815513-2 | Concomitant Disease Progression, Hyperhidrosis, Off Label Use
Adverse event was reported on Jun 30, 2010 by a Male patient taking Scopolamine (View Usage) (Dosage: Unk,unk) was diagnosed with palliative care (What is palliative care?) and. Location: GERMANY , 66 years of age, Patient experienced the following unwanted or unexpected effects: concomitant disease progression, hyperhidrosis, off label use.

6811280-7 | Agitation, Anxiety, Dizziness, Nausea, Retching, Tachyphrenia, Tremor
on Jun 29, 2010 Female patient from UNITED STATES , 33 years of age, weighting 115.0 lb, was diagnosed with motion sickness (What is motion sickness?) and was treated with Scopolamine (View Usage). Patient had the following side effects: agitation, anxiety (What is anxiety?), dizziness (What is dizziness?), nausea (What is nausea?), retching, tachyphrenia, tremor. Scopolamine dosage: Rx'd By Another Md. Patient was hospitalized.

6775744-7 | Off Label Use, Overdose, Pneumonia Aspiration
on Jun 16, 2010 Female patient from UNITED KINGDOM , 28 years of age, was diagnosed with salivary hypersecretion and was treated with Scopolamine (View Usage). After Scopolamine was administered, patient had the following side effects: off label use, overdose, pneumonia aspiration. Scopolamine dosage: 1.5 Df, Q72h. Patient was hospitalized.

6775739-3 | Blood Glucose Decreased, Blood Glucose Fluctuation, Decreased Insulin Requirement
Patient was taking Scopolamine (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose decreased, blood glucose fluctuation, decreased insulin requirement on Jun 14, 2010 from GERMANY Additional patient health information: Male patient , weighting 154.3 lb, was diagnosed with motion sickness (What is motion sickness?) and. Scopolamine dosage: Unk, Unk. During the same period patient was treated with ^ANTIHYPERTONICS^ (View ^antihypertonics^ Review and ^antihypertonics^ Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), LANTUS (View Lantus Review and Lantus Label ), ^LERCARNIDIPINE^ (View ^lercarnidipine^ Review and ^lercarnidipine^ Label ).

6765919-5 | Blood Glucose Decreased, Blood Glucose Fluctuation, Decreased Insulin Requirement
Adverse event was reported on Jun 07, 2010 by a Male patient taking Scopolamine (View Usage) (Dosage: Unk, Unk) was diagnosed with motion sickness (What is motion sickness?) and. Location: GERMANY , weighting 154.3 lb, Patient had the following side effects: blood glucose decreased, blood glucose fluctuation, decreased insulin requirement. During the same period patient was treated with ^ANTIHYPERTONICS^ (View ^antihypertonics^ Review and ^antihypertonics^ Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), LANTUS (View Lantus Review and Lantus Label ).

6626333-6 | Amnesia, Hallucination, Motor Dysfunction, Visual Acuity Reduced
on Feb 25, 2010 Female patient from DENMARK , weighting 130.1 lb, was treated with Scopolamine (View Usage). After Scopolamine was administered, patient had the following side effects: amnesia, hallucination, motor dysfunction, visual acuity reduced. Scopolamine dosage: 1 Mg, Q72h.

6626332-4 | Disability, Overdose
on Mar 03, 2010 Male patient from FRANCE , child 1 years of age, weighting 32.63 lb, was diagnosed with salivary hypersecretion and was treated with Scopolamine (View Usage). Patient experienced the following unwanted or unexpected effects: disability, overdose. Scopolamine dosage: 0.25 Df, Q72h. Patient was hospitalized.

6584940-3 | Malaise, Presbyopia, Pupils Unequal, Tobacco Abuse, Vision Blurred
Patient was taking Scopolamine (View Usage). Patient had the following side effects: malaise, presbyopia, pupils unequal, tobacco abuse, vision blurred on Feb 09, 2010 from GERMANY Additional patient health information: Female patient , weighting 138.9 lb, was diagnosed with prophylaxis against motion sickness and. Scopolamine dosage: Unk, Unk. During the same period patient was treated with SIMVASTATIN (1 Df, Qhs) (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6555859-9 | Off Label Use
Adverse event was reported on Jan 25, 2010 by a Female patient taking Scopolamine (View Usage) (Dosage: Unk, Unk) was diagnosed with palliative care (What is palliative care?) and. Location: GERMANY , 97 years of age, After Scopolamine was administered, patient had the following side effects: off label use.

6550016-4 | Delusion, Hallucination, Nightmare, Somnambulism
on Jan 20, 2010 Male patient from DENMARK , weighting 180.8 lb, was diagnosed with motion sickness (What is motion sickness?) and was treated with Scopolamine (View Usage). Patient experienced the following unwanted or unexpected effects: delusion, hallucination, nightmare, somnambulism. Scopolamine dosage: 1 Mg, Q72h.

6525445-5 | Application Site Erythema, Application Site Inflammation, Pain, Pruritus, Skin Disorder, Skin Reaction
on Dec 23, 2009 Male patient from UNITED KINGDOM , 44 years of age, was treated with Scopolamine (View Usage). Patient had the following side effects: application site erythema, application site inflammation, pain (What is pain?), pruritus, skin disorder, skin reaction. Scopolamine dosage: 1 Df, Q72h. During the same period patient was treated with ASPIRIN AND DIPYRIDAMOLE (2 Df, Qd) (View Aspirin And Dipyridamole Review and Aspirin And Dipyridamole Label ), CLOBAZAM (10 Ml, Bid) (View Clobazam Review and Clobazam Label ), LEVETIRACETAM (1500 Unk, Once/single) (View Levetiracetam Review and Levetiracetam Label ), MIDAZOLAM HCL (10 Ml, Prn) (View Midazolam Hcl Review and Midazolam Hcl Label ), SENOKOT /UNK/ (10 Mg, Qd) (View Senokot /unk/ Review and Senokot /unk/ Label ), TEGRETOL (1000 Mg, Once/single) (View Tegretol Review and Tegretol Label ).

6507992-5 | Epilepsy, Off Label Use
Patient was taking Scopolamine (View Usage). After Scopolamine was administered, patient had the following side effects: epilepsy (What is epilepsy?), off label use on Dec 08, 2009 from FRANCE Additional patient health information: Male patient , child 11 years of age, weighting 74.96 lb, was diagnosed with salivary hypersecretion and. Scopolamine dosage: 1 Mg, 72 Hours. During the same period patient was treated with DEPAKENE (View Depakene Review and Depakene Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6480414-9 | Balance Disorder, Dizziness, Eye Rolling, Flushing, Malaise, Nausea, Visual Impairment
Adverse event was reported on Nov 30, 2009 by a Male patient taking Scopolamine (View Usage) (Dosage: 1 Df, Q72h) was diagnosed with prophylaxis against motion sickness and. Location: GERMANY , 59 years of age, Patient experienced the following unwanted or unexpected effects: balance disorder, dizziness (What is dizziness?), eye rolling, flushing, malaise, nausea (What is nausea?), visual impairment. Patient was hospitalized.

6463950-0 | Agitation, Delirium, Delusion, Psychotic Disorder
on Nov 30, 2009 Male patient from UNITED STATES , 60 years of age, weighting 220.9 lb, was diagnosed with cataract operation and was treated with Scopolamine (View Usage). Patient had the following side effects: agitation, delirium, delusion, psychotic disorder (What is psychotic disorder?). Scopolamine dosage: 1 Drops Bid Eye. Patient was hospitalized.

6456887-4 | Epilepsy, Insomnia, Mydriasis, Off Label Use, Restlessness
on Nov 17, 2009 Male patient from NETHERLANDS , weighting 79.37 lb, was diagnosed with salivary hypersecretion and was treated with Scopolamine (View Usage). After Scopolamine was administered, patient had the following side effects: epilepsy (What is epilepsy?), insomnia, mydriasis, off label use, restlessness. Scopolamine dosage: 1.5 Mg, Qd. During the same period patient was treated with DEPAKENE (300 Mg, Bid) (View Depakene Review and Depakene Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), HYDROCORTISONE (5 Mg, Qd) (View Hydrocortisone Review and Hydrocortisone Label ), BACITRACIN (View Bacitracin Review and Bacitracin Label ), COLISTIN (View Colistin Review and Colistin Label ), GENOTROPIN (12 Mg, Unk) (View Genotropin Review and Genotropin Label ), LEVOTHYROXINE SODIUM (75 Ug, Qd) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), MACROGOL (View Macrogol Review and Macrogol Label ).

6406099-5 | Dizziness, Eye Complication Associated With Device, Nausea, Somnolence, Vestibular Disorder, Visual Impairment, Withdrawal Syndrome
Patient was taking Scopolamine (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), eye complication associated with device, nausea (What is nausea?), somnolence, vestibular disorder, visual impairment, withdrawal syndrome on Oct 16, 2009 from UNITED STATES Additional patient health information: Female patient , 20 years of age, weighting 135.0 lb, was diagnosed with dizziness (What is dizziness?) and. Scopolamine dosage: 1 Patch Every 3 Days Transdermal. Patient was hospitalized and became disabled.

6377297-4 | Blood Potassium Decreased, Blood Sodium Decreased, Confusional State, Dysarthria, Mental Status Changes, Mydriasis, Nausea, Oedema Peripheral, Pain In Extremity
Adverse event was reported on Sep 23, 2009 by a Female patient taking Scopolamine (View Usage) (Dosage: 0.6mg Iv Once) was diagnosed with nausea (What is nausea?), pruritus, rash (What is rash?) and. Location: UNITED STATES , 56 years of age, weighting 316.6 lb, Patient had the following side effects: blood potassium decreased, blood sodium decreased, confusional state, dysarthria, mental status changes, mydriasis, nausea (What is nausea?), oedema peripheral, pain in extremity. During the same period patient was treated with DIPHENHYDRAMINE HCL (50mg Po Once) (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ), HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), BISACODYL (View Bisacodyl Review and Bisacodyl Label ), COLCHINE (View Colchine Review and Colchine Label ), HYDROMORPHONE (View Hydromorphone Review and Hydromorphone Label ), INSULINE GLARGINE (View Insuline Glargine Review and Insuline Glargine Label ).

6315053-3 | Impaired Work Ability, Nausea, Stress
on Aug 18, 2009 Female patient from UNITED STATES , 52 years of age, weighting 185.0 lb, was diagnosed with motion sickness (What is motion sickness?) and was treated with Scopolamine (View Usage). After Scopolamine was administered, patient had the following side effects: impaired work ability, nausea (What is nausea?), stress (What is stress?). Scopolamine dosage: 1 Patch 72 Hours Transdermal.

6306889-3 | Anxiety, Decreased Appetite, Disorientation, Dizziness, Dry Mouth, Dyspnoea, Emotional Disorder, Fatigue, Feeling Abnormal
on Aug 11, 2009 Male patient from UNITED STATES , 47 years of age, weighting 1156 lb, was diagnosed with motion sickness (What is motion sickness?) and was treated with Scopolamine (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), decreased appetite, disorientation, dizziness (What is dizziness?), dry mouth, dyspnoea, emotional disorder, fatigue, feeling abnormal. Scopolamine dosage: 1 Patch Every Three Days Transdermal.

6228159-4 | Activities Of Daily Living Impaired, Dizziness, Fear, Impaired Driving Ability, Impaired Work Ability, Motion Sickness, Paranoia
Patient was taking Scopolamine (View Usage). Patient had the following side effects: activities of daily living impaired, dizziness (What is dizziness?), fear, impaired driving ability, impaired work ability, motion sickness (What is motion sickness?), paranoia on Jun 10, 2009 from UNITED STATES Additional patient health information: Female patient , 36 years of age, weighting 110.0 lb, . Scopolamine dosage: .

6121801-8 | Mental Status Changes, Unresponsive To Stimuli
Adverse event was reported on Mar 13, 2009 by a Male patient taking Scopolamine (View Usage) (Dosage: 0.4 Mg Once Iv) was diagnosed with nausea (What is nausea?) and. Location: UNITED STATES , 87 years of age, weighting 147.5 lb, After Scopolamine was administered, patient had the following side effects: mental status changes, unresponsive to stimuli. Patient was hospitalized.

6107972-8 | Asthenopia, Confusional State, Vision Blurred
on Mar 05, 2009 Female patient from UNITED STATES , 38 years of age, weighting 150.0 lb, was diagnosed with prophylaxis of nausea and vomiting and was treated with Scopolamine (View Usage). Patient experienced the following unwanted or unexpected effects: asthenopia, confusional state, vision blurred. Scopolamine dosage: 1 Patch 1 Transdermal.

6086700-9 | Accidental Exposure, Dysarthria, Erythema, Formication, Mydriasis, Neuropathy Peripheral, Off Label Use, Paraesthesia
on Jan 24, 2009 Female patient from UNITED STATES , 49 years of age, weighting 115.1 lb, was diagnosed with vertigo and was treated with Scopolamine (View Usage). Patient had the following side effects: accidental exposure, dysarthria, erythema, formication, mydriasis, neuropathy peripheral, off label use, paraesthesia. Scopolamine dosage: 1.5 Mg, Once/single, Transdermal. Patient was hospitalized.

6029412-X | Anxiety, Contusion, Delirium, Disorientation, Fall, Hallucination, Visual, Judgement Impaired, Malaise, Psychotic Disorder
Patient was taking Scopolamine (View Usage). After Scopolamine was administered, patient had the following side effects: anxiety (What is anxiety?), contusion, delirium, disorientation, fall (What is fall?), hallucination, visual, judgement impaired, malaise, psychotic disorder (What is psychotic disorder?) on Dec 24, 2008 from CANADA Additional patient health information: Male patient , 79 years of age, was diagnosed with prophylaxis of nausea and vomiting and. Scopolamine dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), PLAVIX (View Plavix Review and Plavix Label ), ALTACE (View Altace Review and Altace Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), MONOCOR (BISOPROLOL FUMARATE) (View Monocor (bisoprolol Fumarate) Review and Monocor (bisoprolol Fumarate) Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), EZETROL (EZETIMIBE) (View Ezetrol (ezetimibe) Review and Ezetrol (ezetimibe) Label ).

6028015-0 | Sinus Bradycardia, Tachycardia
Adverse event was reported on Dec 10, 2008 by a Male patient taking Scopolamine (View Usage) (Dosage: 1 Mg, Q72h, Transdermal) was diagnosed with salivary hypersecretion and. Location: FRANCE , 57 years of age, Patient experienced the following unwanted or unexpected effects: sinus bradycardia, tachycardia. During the same period patient was treated with DEPAKENE (View Depakene Review and Depakene Label ), FLUPHENAZINE HCL (View Fluphenazine Hcl Review and Fluphenazine Hcl Label ), HALDOL (HALOPERIDOL DECANOATE) (View Haldol (haloperidol Decanoate) Review and Haldol (haloperidol Decanoate) Label ), DIHYDROERGOTAMINE MESYLATE (View Dihydroergotamine Mesylate Review and Dihydroergotamine Mesylate Label ).

6002996-3 | Anxiety, Contusion, Delirium, Disorientation, Fall, Hallucination, Visual, Joint Injury, Judgement Impaired, Malaise
on Dec 02, 2008 Male patient from CANADA , 79 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with Scopolamine (View Usage). Patient had the following side effects: anxiety (What is anxiety?), contusion, delirium, disorientation, fall (What is fall?), hallucination, visual, joint injury, judgement impaired, malaise. Scopolamine dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), PLAVIX (View Plavix Review and Plavix Label ), ALTACE (View Altace Review and Altace Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), MONOCOR (BISOPROLOL FUMARATE) (View Monocor (bisoprolol Fumarate) Review and Monocor (bisoprolol Fumarate) Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), EZETROL (EZETIMIBE) (View Ezetrol (ezetimibe) Review and Ezetrol (ezetimibe) Label ).

5999709-8 | Nausea
on Dec 11, 2008 Female patient from UNITED STATES , 52 years of age, weighting 190.0 lb, was diagnosed with prophylaxis against motion sickness and was treated with Scopolamine (View Usage). After Scopolamine was administered, patient had the following side effects: nausea (What is nausea?). Scopolamine dosage: 1 Patch Q 72 Hours Transdermal.

5997037-8 | Hallucination, Malaise, Psychotic Disorder
Patient was taking Scopolamine (View Usage). Patient experienced the following unwanted or unexpected effects: hallucination, malaise, psychotic disorder (What is psychotic disorder?) on Nov 27, 2008 from CANADA Additional patient health information: Male patient , 79 years of age, . Scopolamine dosage: .

5957704-9 | Application Site Erythema, Application Site Irritation, Blister, Gastrostomy, Inflammation, Lung Abscess, Oesophagogastric Fundoplasty, Wound Secretion
Adverse event was reported on Nov 07, 2008 by a Female patient taking Scopolamine (View Usage) (Dosage: 1/3 Patch Every 3 Days, Transdermal; 0.5 Df, Qod, Transdermal; 0.5 Df, Q72h, Transdermal) was diagnosed with increased bronchial secretion and. Location: FRANCE , 18 years of age, weighting 30.86 lb, Patient had the following side effects: application site erythema, application site irritation, blister, gastrostomy, inflammation, lung abscess, oesophagogastric fundoplasty, wound secretion. During the same period patient was treated with CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), TEGRETOL (View Tegretol Review and Tegretol Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

5942606-4 | Application Site Erythema, Application Site Irritation, Blister, Dermatitis, Dysphagia, Eczema, Lung Abscess, Off Label Use, Wound Secretion
on Oct 24, 2008 Female patient from FRANCE , 18 years of age, weighting 30.86 lb, was diagnosed with increased bronchial secretion and was treated with Scopolamine (View Usage). After Scopolamine was administered, patient had the following side effects: application site erythema, application site irritation, blister, dermatitis, dysphagia, eczema (What is eczema?), lung abscess, off label use, wound secretion. Scopolamine dosage: Transdermal. Patient was hospitalized.

5930400-X | Activities Of Daily Living Impaired, Anosmia, Olfactory Test Abnormal, Parosmia
on Oct 16, 2008 Male patient from FRANCE , 69 years of age, was diagnosed with prophylaxis against motion sickness and was treated with Scopolamine (View Usage). Patient experienced the following unwanted or unexpected effects: activities of daily living impaired, anosmia, olfactory test abnormal, parosmia. Scopolamine dosage: 1 Df, Q72h, Transdermal. During the same period patient was treated with ATACAND (View Atacand Review and Atacand Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

5901512-1 | Delirium, Hallucination, Visual, Incoherent, Overdose, Persecutory Delusion
Patient was taking Scopolamine (View Usage). Patient had the following side effects: delirium, hallucination, visual, incoherent, overdose, persecutory delusion on Aug 22, 2008 from FRANCE Additional patient health information: Female patient , 66 years of age, was diagnosed with dizziness (What is dizziness?) and. Scopolamine dosage: Transdermal; 2 Patches At The Same Time, Transdermal. Patient was hospitalized.

5895054-X | Balance Disorder, Dizziness, Feeling Hot, Nausea, Tremor, Visual Impairment
Adverse event was reported on Sep 11, 2008 by a Female patient taking Scopolamine (View Usage) (Dosage: Trandermal) was diagnosed with motion sickness (What is motion sickness?) and. Location: GERMANY , 29 years of age, weighting 132.3 lb, After Scopolamine was administered, patient had the following side effects: balance disorder, dizziness (What is dizziness?), feeling hot, nausea (What is nausea?), tremor, visual impairment. During the same period patient was treated with FEMIGOA (ETHINYLESTRADIOL, EVONORGESTREL) (View Femigoa (ethinylestradiol, Evonorgestrel) Review and Femigoa (ethinylestradiol, Evonorgestrel) Label ).

5895053-8 | Application Site Discharge, Application Site Erythema, Application Site Irritation, Application Site Vesicles, Lung Abscess, Off Label Use
on Sep 11, 2008 Female patient from FRANCE , 18 years of age, weighting 30.86 lb, was diagnosed with increased bronchial secretion and was treated with Scopolamine (View Usage). Patient experienced the following unwanted or unexpected effects: application site discharge, application site erythema, application site irritation, application site vesicles, lung abscess, off label use. Scopolamine dosage: 1/3 Patch Every 3 Days; Transdermal. Patient was hospitalized.

5873100-7 | Delirium, Hallucination, Visual, Incoherent, Off Label Use, Overdose, Persecutory Delusion
on Aug 22, 2008 Female patient from FRANCE , 66 years of age, was diagnosed with dizziness (What is dizziness?) and was treated with Scopolamine (View Usage). Patient had the following side effects: delirium, hallucination, visual, incoherent, off label use, overdose, persecutory delusion. Scopolamine dosage: Transdermal; 2 Patches At The Same Time, Transdermal. Patient was hospitalized.

5869320-8 | Confusional State, Cough, Disorientation, Dry Eye, Dry Mouth, Eye Disorder, Eye Swelling, Feeling Hot
Patient was taking Scopolamine (View Usage). After Scopolamine was administered, patient had the following side effects: confusional state, cough, disorientation, dry eye, dry mouth, eye disorder, eye swelling, feeling hot on Jul 15, 2008 from IRELAND Additional patient health information: Female patient , 65 years of age, was diagnosed with increased bronchial secretion and. Scopolamine dosage: 1 Patch, Transdermal; 1/2 [atch, Transermal; 0.25 Df, Q72h, Transdermal. During the same period patient was treated with XANAX (View Xanax Review and Xanax Label ), LUSTRAL (SERTRALINE HYDROCHLORIDE) (View Lustral (sertraline Hydrochloride) Review and Lustral (sertraline Hydrochloride) Label ), LIORESAL (View Lioresal Review and Lioresal Label ), CALOGEN (ARACHIS HYPOGAEA OIL) (View Calogen (arachis Hypogaea Oil) Review and Calogen (arachis Hypogaea Oil) Label ), TPN ELECTROLYTES IN PLASTIC CONTAINER (View Tpn Electrolytes In Plastic Container Review and Tpn Electrolytes In Plastic Container Label ), CORSODYL (CHLORHEXIDINE GLUCONATE) (View Corsodyl (chlorhexidine Gluconate) Review and Corsodyl (chlorhexidine Gluconate) Label ).

5827149-0 | Confusional State, Cough, Disorientation, Dry Eye, Dry Mouth, Erythema, Eye Disorder, Eye Swelling
Adverse event was reported on Jul 15, 2008 by a Female patient taking Scopolamine (View Usage) (Dosage: 1 Patch, Transdermal, 1/2 Patch, Transdermal, 0.25 Df, Q72h, Transdermal) was diagnosed with increased bronchial secretion and. Location: IRELAND , 65 years of age, Patient experienced the following unwanted or unexpected effects: confusional state, cough, disorientation, dry eye, dry mouth, erythema, eye disorder, eye swelling. During the same period patient was treated with CORDISOL (View Cordisol Review and Cordisol Label ), XANAX (View Xanax Review and Xanax Label ), LUSTRAL (SERTRALINE HYDROCHLORIDE) TABLET (View Lustral (sertraline Hydrochloride) Tablet Review and Lustral (sertraline Hydrochloride) Tablet Label ), LIORESAL (View Lioresal Review and Lioresal Label ), CALOGEN /IRE/ (ARACHIS HYPOGAEA OIL) (View Calogen /ire/ (arachis Hypogaea Oil) Review and Calogen /ire/ (arachis Hypogaea Oil) Label ), JEVITY (CORN OIL, ELECTROLYTES NOS, FATTY ACIDS NOS, GLYCINE MAX SEED (View Jevity (corn Oil, Electrolytes Nos, Fatty Acids Nos, Glycine Max Seed Review and Jevity (corn Oil, Electrolytes Nos, Fatty Acids Nos, Glycine Max Seed Label ).

5810983-0 | Asthenia, Cerebellar Syndrome, Cough, Decreased Appetite, Diarrhoea, Dysstasia, Pyrexia
on Jun 30, 2008 Female patient from FRANCE , 70 years of age, was diagnosed with prophylaxis against motion sickness and was treated with Scopolamine (View Usage). Patient had the following side effects: asthenia, cerebellar syndrome, cough, decreased appetite, diarrhoea, dysstasia, pyrexia. Scopolamine dosage: Transdermal. During the same period patient was treated with FOSINOPRIL SODIUM (View Fosinopril Sodium Review and Fosinopril Sodium Label ), SERC (View Serc Review and Serc Label ). Patient was hospitalized.

5808323-6 | Concomitant Disease Progression, Off Label Use
on Jun 05, 2008 Male patient from IRELAND , 74 years of age, was diagnosed with salivary hypersecretion and was treated with Scopolamine (View Usage). After Scopolamine was administered, patient had the following side effects: concomitant disease progression, off label use. Scopolamine dosage: 1 Df, Q72h, Transdermal; 2 Df Q72h, Transdermal.

5776479-X | Off Label Use, Urinary Retention, Urinary Tract Infection
Patient was taking Scopolamine (View Usage). Patient experienced the following unwanted or unexpected effects: off label use, urinary retention, urinary tract infection (What is urinary tract infection?) on Jun 06, 2008 from FRANCE Additional patient health information: Female patient , 22 years of age, weighting 66.14 lb, was diagnosed with salivary hypersecretion and. Scopolamine dosage: 1 Mg, Q72h, Transdermal.

5776475-2 | Concomitant Disease Progression
Adverse event was reported on Jun 05, 2008 by a Male patient taking Scopolamine (View Usage) (Dosage: 1 Df, Q72h, Transdermal; 2 Df, Q72h, Transdermal) . Location: IRELAND , 74 years of age, Patient had the following side effects: concomitant disease progression.

5758756-1 | Agitation, Aphasia, Balance Disorder, Delirium, Disorientation, Hallucination, Iris Disorder, Mental Disorder, Micturition Disorder
on May 19, 2008 Female patient from FRANCE , 64 years of age, weighting 101.4 lb, was diagnosed with motion sickness (What is motion sickness?), prophylaxis and was treated with Scopolamine (View Usage). After Scopolamine was administered, patient had the following side effects: agitation, aphasia (What is aphasia?), balance disorder, delirium, disorientation, hallucination, iris disorder, mental disorder, micturition disorder. Scopolamine dosage: 1 Mg, Transdermal. During the same period patient was treated with AVLOCARDYL (PROPRANOLOL) (View Avlocardyl (propranolol) Review and Avlocardyl (propranolol) Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ).

5743796-9 | Dizziness, Nausea
on May 19, 2008 Female patient from UNITED STATES , 63 years of age, weighting 124.0 lb, was diagnosed with motion sickness (What is motion sickness?) and was treated with Scopolamine (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), nausea (What is nausea?). Scopolamine dosage: 1.5 1 Patch For 2 Days.

5646864-5 | Asthenia, Gait Disturbance, Incoherent
Patient was taking Scopolamine (View Usage). Patient had the following side effects: asthenia, gait disturbance, incoherent on Feb 29, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 137.0 lb, was diagnosed with motion sickness (What is motion sickness?) and. Scopolamine dosage: Daily Sept - On Cruise.